Sarah Cannon Research Institute (SCRI)

London W1G 6AD

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Myelodysplastic Syndromes, Non-small Cell Lung Carcinoma

Studies at this site

• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer — Running, not enrolling